Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 31, 2015 3:44 PM ET

Diversified Consumer Services

Company Overview of University of Leicester

Company Overview

University of Leicester is an educational institution that offers graduate and postgraduate programs in biochemistry, bioengineering, cancer study, economics, arts, finance, genetics, historical studies, language, marketing, sociology, translational therapeutics, and urban history. The institution also provides distance learning courses and research degrees which include PhD, MPhil, and professional doctorates. University of Leicester was founded in 1921 and is based in Leicester, United Kingdom.

University Road

Leicester,  LE1 7RH

United Kingdom

Founded in 1921

Phone:

44 11 6252 2522

Fax:

44 11 6252 2200

Key Executives for University of Leicester

Head of the College of Science and Engineering
Director of Estates
Compensation as of Fiscal Year 2015.

University of Leicester Key Developments

University of Leicester to Cut Jobs

University of Leicester announced that about 80 staff face the axe as the University of Leicester looks to make savings. The university employs about 3,000 staff and say the measures amount to 1.8% of total employee costs which it is seeking though voluntary means.

AmpliPhi BioSciences Corporation Signs Collaboration and License Agreements with University of Leicester

AmpliPhi BioSciences Corporation announced it has entered into Collaboration and License Agreements with University of Leicester to develop a novel bacteriophage therapy targeting Clostridium difficile (C. difficile), a serious gastrointestinal infection for which new treatments are urgently required. Under the terms of the agreements, AmpliPhi will fund Dr. Martha Clokie's team at the University of Leicester to progress non-clinical studies of bacteriophage products as an alternative to treating antibiotic resistant infections caused by C. difficile bacteria. Evaluations of the efficacy of bacteriophage therapy will be carried out at the University of Glasgow, UK, in the laboratory of Dr. Gill Douce, under a three-way collaborative project between AmpliPhi, Leicester and Glasgow. C. difficile infection is widely accepted to be the leading cause of hospital-acquired (or nosocomial) infection-related morbidity and mortality, outpacing both antibiotic-resistant staphylococcus (MRSA) and enterococcus (VRE).

Similar Private Companies By Industry

Company Name Region
Oranges and Lemons Limited Europe
Northwood College Europe
Initial Hospital Services Ltd. Europe
Play Station Nursery Ltd Europe
Accouter Design Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact University of Leicester, please visit www2.le.ac.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.